The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
The tumour microenvironment as a target for chemoprevention
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,482
Robbins and Cotran Pathologic Basis of Disease
Hoda, S. A., & Hoda, R. S. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa163 · Cited by 3,365
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Ryter, S. W., Alam, J., & Choi, A. M. K. (2006) · Physiological Reviews · doi:10.1152/physrev.00011.2005 · Cited by 2,307
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Robbins and Cotran Pathologic Basis of Disease
Hoda, S. A., & Hoda, R. S. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000155072.86944.7d · Cited by 1,571
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Solomon, S. D., Kim, K., Tang, J., Rosenstein, R. B., Wittes, J., Corle, D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061355 · Cited by 1,048
Celecoxib for the Prevention of Colorectal Adenomatous Polyps
Arber, N., Eagle, C. J., Spicak, J., Rácz, I., Dite, P., Hajer, J., Zavoral, M., Lechuga, M. J., Gerletti, P., Tang, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061652 · Cited by 975
Myofibroblasts. I. Paracrine cells important in health and disease
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & West, A. B. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.1.c1 · Cited by 924
Stromal Effects on Mammary Gland Development and Breast Cancer
Wiseman, B. S., & Werb, Z. (2002) · Science · doi:10.1126/science.1067431 · Cited by 923
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
Demierre, M.-F., Higgins, P. D. R., Gruber, S. B., Hawk, E., & Lippman, S. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1751 · Cited by 819
Calle, E. E., & Thun, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207751 · Cited by 769
Sporn, M. B. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91015-6 · Cited by 692
Self-citationHypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
Semenza, G. L. (2000) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230091169186 · Cited by 654
Therapeutic targeting of the tumor microenvironment
Joyce, J. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.024 · Cited by 582
Huang, S., Pettaway, C. A., Uehara, H., Bucana, C. D., & Fidler, I. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204535 · Cited by 556
Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017400 · Cited by 532
Nrf2 as a novel molecular target for chemoprevention
Lee, J.-S., & Surh, Y.-J. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.09.042 · Cited by 516
Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?
Kerbel, R. S. (2006) · Science · doi:10.1126/science.1125950 · Cited by 466
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 444
De Backer, G., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200308000-00004 · Cited by 440
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
Tran, J., Master, Z., Yu, J. L., Rak, J., Dumont, D. J., & Kerbel, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072586399 · Cited by 434
The hypoxic response of tumors is dependent on their microenvironment
Blouw, B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H.-P., Johnson, R. S., & Bergers, G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00194-6 · Cited by 408
Stat3 regulates genes common to both wound healing and cancer
Dauer, D. J., Ferraro, B., Song, L., Yu, B., Mora, L., Buettner, R., Enkemann, S., Jove, R., & Haura, E. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208469 · Cited by 380
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & Ab, W. (1999) · Cited by 358
Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc min mice
Myzak, M. C., Dashwood, W. M., Orner, G. A., Ho, E., & Dashwood, R. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-4785fje · Cited by 344
Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial Cells
O'Connor, D. S., Schechner, J. S., Adida, C., Mesri, M., Rothermel, A. L., Li, F., Nath, A. K., Pober, J. S., & Altieri, D. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64742-6 · Cited by 341
Donà, M., Dell’Aica, I., Calabrese, F., Benelli, R., Morini, M., Albini, A., & Garbisa, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4335 · Cited by 333
Self-citation‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents
Tosetti, F., Ferrari, N., De Flora, S., & Albini, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0300rev · Cited by 324
Self-citationSmad4 signalling in T cells is required for suppression of gastrointestinal cancer
Kim, B.-G., Li, C., Qiao, W., Mamura, M., Kasperczak, B., Anver, M., Wolfraim, L., Hong, S., Mushinski, E., Potter, M., et al. (2006) · Nature · doi:10.1038/nature04846 · Cited by 322
Lymphoma-Specific Genetic Aberrations in Microvascular Endothelial Cells in B-Cell Lymphomas
Streubel, B., Chott, A., Huber, D., Exner, M., Jäger, U., Wagner, O., & Schwarzinger, I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033153 · Cited by 318
Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways
Fang, J., Xia, C., Cao, Z., Zheng, J. Z., Reed, E., & Jiang, B.-H. (2005) · The FASEB Journal · doi:10.1096/fj.04-2175com · Cited by 312
Xu, C., Shen, G., Chen, C., Gélinas, C., & Kong, A.-N. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208656 · Cited by 301
NF‐κB and cancer: Mechanisms and targets
Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 298
BISSELL, M. J., KENNY, P. A., & RADISKY, D. C. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.013 · Cited by 298
DVORAK, H. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01361.x · Cited by 296
Talalay, P., Dinkova-Kostova, A. T., & Holtzclaw, W. D. (2003) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(02)00038-9 · Cited by 289
De Backer, G., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2003) · European Journal of Cardiovascular Prevention and Rehabilitation · doi:10.1097/00149831-200312001-00001 · Cited by 274
Solomon, S. D., Pfeffer, M. A., McMurray, J. J. V., Fowler, R., Finn, P., Levin, B., Eagle, C., Hawk, E., Lechuga, M., Zauber, A. G., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.636746 · Cited by 273
Overview of mechanisms of cancer chemopreventive agents
De Flora, S., & Ferguson, L. R. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.02.029 · Cited by 272
Kelloff, G. J., Lippman, S. M., Dannenberg, A. J., Sigman, C. C., Pearce, H. L., Reid, B. J., Szabo, E., Jordan, V. C., Spitz, M. R., Mills, G. B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1104 · Cited by 270
Freedman, A. N., Graubard, B. I., Rao, S. R., McCaskill-Stevens, W., Ballard-Barbash, R., & Gail, M. H. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.526 · Cited by 260
Zhu, P., Baek, S. H., Bourk, E. M., Ohgi, K. A., Garcia-Bassets, I., Sanjo, H., Akira, S., Kotol, P. F., Glass, C. K., Rosenfeld, M. G., et al. (2006) · Cell · doi:10.1016/j.cell.2005.12.032 · Cited by 259
Kong, X., Lin, Z., Liang, D., Fath, D., Sang, N., & Caro, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2019-2028.2006 · Cited by 258
Context, tissue plasticity, and cancerAre tumor stem cells also regulated by the microenvironment?
BISSELL, M., & LABARGE, M. (2005) · Cancer Cell · doi:10.1016/s1535-6108(04)00375-7 · Cited by 255
Palumbo, J. S., Potter, J. M., Kaplan, L. S., Talmage, K. E., Jackson, D. G., & Degen, J. L. (2002) · PubMed · Cited by 253
Huang, S., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · PubMed · Cited by 250
Scapini, P., Morini, M., Tecchio, C., Minghelli, S., Di Carlo, E., Tanghetti, E., Albini, A., Lowell, C., Berton, G., Noonan, D. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.5034 · Cited by 249
Self-citationThe Survivin saga goes in vivo
Reed, J. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14123 · Cited by 232
A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway
Zhang, Y., & Gordon, G. B. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.885.3.7 · Cited by 226
Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
Veronesi, U., Mariani, L., Decensi, A., Formelli, F., Camerini, T., Miceli, R., Di Mauro, M. G., Costa, A., Marubini, E., Sporn, M. B., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl047 · Cited by 217
Self-citationReduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-27 · Cited by 214
Cellular adaptation in the origin and development of cancer.
Farber, E., & Rubin, H. (1991) · PubMed · Cited by 205
Zhang, Q., Tang, X., Lu, Q. Y., Zhang, Z. F., Brown, J., & Le, A. D. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0198 · Cited by 202
Tumor Inflammatory Angiogenesis and Its Chemoprevention
Albini, A., Tosetti, F., Benelli, R., & Noonan, D. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3473 · Cited by 194
Self-citationBenelli, R., Morini, M., Carrozzino, F., Ferrari, N., Minghelli, S., Santi, L., Cassatella, M., Noonan, D. M., & Albini, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0651fje · Cited by 188
Self-citationGenetic evidence for a tumor suppressor role of HIF-2α
Acker, T., Diez-Juan, A., Aragones, J., Tjwa, M., Brusselmans, K., Moons, L., Fukumura, D., Moreno-Murciano, M. P., Herbert, J.-M., Burger, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.003 · Cited by 184
Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF‐κB and Akt as targets
Albini, A., Dell'Eva, R., Vené, R., Ferrari, N., Buhler, D. R., Noonan, D. M., & Fassina, G. (2006) · The FASEB Journal · doi:10.1096/fj.05-5128fje · Cited by 177
Self-citationBertl, E., Bartsch, H., & Gerhäuser, C. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0324 · Cited by 169
Bindra, R. S., & Glazer, P. M. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.03.013 · Cited by 168
Zhang, Q., Tang, X., Lu, Q., Zhang, Z., Rao, J., & Le, A. D. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0490 · Cited by 168
Mechanisms of Disease: inflammatory mediators and cancer prevention
Mann, J. R., Backlund, M. G., & DuBois, R. N. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0140 · Cited by 167
Angiogenesis in rheumatoid arthritis.
Maruotti, N., Cantatore, F. P., Crivellato, E., Vacca, A., & Ribatti, D. (2006) · PubMed · doi:10.14670/hh-21.557 · Cited by 162
A New Perspective on Tumor Endothelial Cells: Unexpected Chromosome and Centrosome Abnormalities
Hida, K., & Klagsbrun, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0002 · Cited by 160
Cancer chemoprevention: scientific promise, clinical uncertainty
Sporn, M. B., & Liby, K. T. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0319 · Cited by 158
Self-citationXiang, R., Mizutani, N., Luo, Y., Chiodoni, C., Zhou, H., Mizutani, M., Ba, Y., Becker, J. C., & Reisfeld, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.553.65.2 · Cited by 158
Buteau-Lozano, H., Ancelin, M., Lardeux, B. R., Milanini, J., & Perrot‐Applanat, M. (2002) · PubMed · Cited by 147
Singh, R. P., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2004) · Oncogene · doi:10.1038/sj.onc.1208276 · Cited by 139
Transcriptional regulation of vascular endothelial growth factor in cancer
LOUREIRO, R., & D'Amore, P. A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.005 · Cited by 133
The Epigenome as a Target for Cancer Chemoprevention
Kopelovich, L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dig109 · Cited by 124
Validating and Improving Models for Projecting the Absolute Risk of Breast Cancer
Gail, M. H., & Costantino, J. P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.334 · Cited by 124
Liby, K. T., Voong, N., Williams, C. R., Risingsong, R., Royce, D. B., Honda, T., Gribble, G. W., Sporn, M. B., & Letterio, J. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0215 · Cited by 117
Self-citationFath, D. M., Kong, X., Liang, D., Lin, Z., Chou, A. D., Jiang, Y., Fang, J., Caro, J., & Sang, N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600456200 · Cited by 116
Inflammation and cancer: the long reach of Ras
Karin, M. (2005) · Nature Medicine · doi:10.1038/nm0105-20 · Cited by 109
The Hypoxia-Inducible Factor and Tumor Progression Along the Angiogenic Pathway
Brahimi-Horn, M. C., & Pouysségur, J. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42004-x · Cited by 99
Weber, F., Shen, L., Fukino, K., Patócs, A., Mutter, G. L., Caldés, T., & Eng, C. (2006) · The American Journal of Human Genetics · doi:10.1086/504090 · Cited by 96
Cancer: the matrix is now in control
Comoglio, P. M., & Trusolino, L. (2005) · Nature Medicine · doi:10.1038/nm1105-1156 · Cited by 96
Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh, N., Roberts, A. B., Reffey, S. B., Miyazono, K., Itoh, S., ten Dijke, P., Heiß, E. H., Place, A. E., Risingsong, R., Williams, C. R., et al. (2003) · PubMed · Cited by 90
Self-citationShao, J., Sheng, G. G., Mifflin, R. C., Powell, D. W., & Sheng, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2606 · Cited by 88
Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas
Ishiguro, K., Yoshida, T., Yagishita, H., Numata, Y., & Okayasu, T. (2005) · Gut · doi:10.1136/gut.2005.079459 · Cited by 83
Ferrari, N., Pfeffer, U., Dell’Eva, R., Ambrosini, C., Noonan, D. M., & Albini, A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2210 · Cited by 75
Self-citationClark, W. H. (1995) · Acta Oncologica · doi:10.3109/02841869509093632 · Cited by 72
HIF, a missing link between metabolism and cancer
Esteban, M. A., & Maxwell, P. H. (2005) · Nature Medicine · doi:10.1038/nm1005-1047 · Cited by 69
The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF- B pathway
Dell’Eva, R., Ambrosini, C., Minghelli, S., Noonan, D. M., Albini, A., & Ferrari, N. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl162 · Cited by 61
Self-citationYen, W.-C., Prudente, R. Y., Corpuz, M., Negro-Vilar, A. F., & Lamph, W. W. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602995 · Cited by 56
Neutrophils and Angiogenesis: Potential Initiators of the Angiogenic Cascade
Benelli, R., Albini, A., & Noonan, D. M. (2003) · KARGER eBooks · doi:10.1159/000071560 · Cited by 53
Self-citationShishodia, S., Gutierrez‐Barrera, A. M., Lotan, R., & Aggarwal, B. B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1585 · Cited by 48
Lippman, S. M., & Lee, J. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4573 · Cited by 42
Selecting targets for cancer prevention: where do we go from here?
Szabo, E. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2008 · Cited by 35
Cited by
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
Zhou, Z., Song, J., Nie, L., & Chen, X. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00271d · Cited by 2,098
Phenotype molding of stromal cells in the lung tumor microenvironment
Lambrechts, D., Wauters, E., Boeckx, B., Aibar, S., Nittner, D., Burton, O., Bassez, A., Decaluwé, H., Pircher, A., Van den Eynde, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0096-5 · Cited by 1,648
Pitt, J. M., Marabelle, A., Eggermont, A., Soria, J.-C., Kroemer, G., & Zitvogel, L. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw168 · Cited by 1,338
Cancer as an overhealing wound: an old hypothesis revisited
Schäfer, M., & Werner, S. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2455 · Cited by 956
Metadata
- Authors
- Albini, A., & Sporn, M. B.
- Venue
- Nature Reviews Cancer
- Published
- 2007-02
- Volume
- 7
- Issue
- 2
- Pages
- 139-147
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2059888416
- Cited by
- 823
- References
- 109
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.